Cargando…

Letrozole in the extended adjuvant setting: MA.17

Detalles Bibliográficos
Autor principal: Goss, Paul E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969900/
http://dx.doi.org/10.1007/s10549-007-9849-4
_version_ 1782445866971299840
author Goss, Paul E.
author_facet Goss, Paul E.
author_sort Goss, Paul E.
collection PubMed
description
format Online
Article
Text
id pubmed-4969900
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-49699002016-08-17 Letrozole in the extended adjuvant setting: MA.17 Goss, Paul E. Breast Cancer Res Treat Erratum Springer US 2008-01-15 2008 /pmc/articles/PMC4969900/ http://dx.doi.org/10.1007/s10549-007-9849-4 Text en © Springer Science+Business Media, LLC. 2008
spellingShingle Erratum
Goss, Paul E.
Letrozole in the extended adjuvant setting: MA.17
title Letrozole in the extended adjuvant setting: MA.17
title_full Letrozole in the extended adjuvant setting: MA.17
title_fullStr Letrozole in the extended adjuvant setting: MA.17
title_full_unstemmed Letrozole in the extended adjuvant setting: MA.17
title_short Letrozole in the extended adjuvant setting: MA.17
title_sort letrozole in the extended adjuvant setting: ma.17
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969900/
http://dx.doi.org/10.1007/s10549-007-9849-4
work_keys_str_mv AT gosspaule letrozoleintheextendedadjuvantsettingma17